| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $47.4M | +10.1% |
| Cost of Revenue | $5.9M | +17.6% |
| Gross Profit | $41.5M | +9.1% |
| R&D Expense | $15.0M | +7.9% |
| SG&A Expense | $27.4M | +81.2% |
| Operating Income | -$28.0M | -937.5% |
| Pre-tax Income | $5.1M | +188.9% |
| Income Tax | $0 | — |
| Net Income | $5.1M | +188.9% |
| EPS (Basic) | $0.14 | +140.0% |
| EPS (Diluted) | $0.13 | +137.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $24.6M | — |
| Accounts Receivable | $3.3M | +11.5% |
| Current Assets | $30.4M | +8401.6% |
| Total Assets | $32.7M | -64.1% |
| Current Liabilities | $9.8M | +305.9% |
| Total Liabilities | $39.1M | +237.9% |
| Stockholders' Equity | -$6.4M | +42.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$28.1M | -2005.9% |
| Investing Cash Flow | -$2.5M | -106.2% |
| Financing Cash Flow | $27.1M | +170.3% |